Tweenvest Stocks

Freenome, Inc. (NasdaqCM: FRNM)

Health Care · Biotechnology · US

$16.32

+2.06% today · +53.5% 1Y

Freenome, Inc. (NasdaqCM: FRNM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.75B and employs 378 people.

Over the last twelve months the share price has gained 53.5%, trading between 9.95 and 17.50.

Tweenvest scores Freenome, Inc. across four factors: quality 33/100, value 57/100. Its strongest factor is value.

FRNM price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.75B
Revenue (TTM)
$35.41M
P/E
—
EPS
-8.84
Dividend yield
—
Beta (5Y)
0.45
52-week high
$17.50
52-week low
$9.95
Avg volume (3M)
—
Shares outstanding
107.45M
Employees
378
Next earnings
—

About Freenome, Inc.

Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).

ISIN
US35661P1003
Founded
2014
Listed since
Jul 21, 2026
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Mesoblast LimitedASX: MSB$1.84BAU$2.04-5.56%
Pell Bio-Med Technology Co., Ltd.TWSE: 6949$1.83BNT$44.50-11.53%
Biohaven Ltd.NYSE: BHVN$1.79B$12.34+3.87%
Hualan Biological Vaccine Inc.SZSE: 301207$1.78BCN¥20.11+4.25%
Mabwell (Shanghai) Bioscience Co., Ltd.SHSE: 688062$1.73BCN¥27.04+2.15%
Shanghai OPM Biosciences Co., Ltd.SHSE: 688293$1.69BCN¥79.61+2.79%
PYC Therapeutics LimitedASX: PYC$1.68BAU$2.46-12.77%
Novoprotein Scientific Inc.SHSE: 688137$1.66BCN¥160.39+28.06%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.